GEO Accession viewer

GSM6034918	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_04_D]
GSM6034919	Feces of a patient affected by limited (ACA) sclerodermia [F_05_L]
GSM6034920	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_06_D]
GSM6034921	Feces of a patient affected by limited (ACA) sclerodermia [F_07_L]
GSM6034922	Feces of a patient affected by limited (ACA) sclerodermia [F_08_L]
GSM6034923	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_09_D]
GSM6034924	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_10_D]
GSM6034925	Feces of a patient affected by limited (ACA) sclerodermia [F_11_L]
GSM6034926	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_12_D]
GSM6034927	Feces of a patient affected by limited (ACA) sclerodermia [F_13_L]
GSM6034928	Feces of a patient affected by limited (ACA) sclerodermia [F_14_L]
GSM6034929	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_15_D]
GSM6034930	Feces of a patient affected by limited (ACA) sclerodermia [F_16_L]
GSM6034931	Feces of a patient affected by limited (ACA) sclerodermia [F_17_L]
GSM6034932	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_18_D]
GSM6034933	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_19_D]
GSM6034934	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_20_D]
GSM6034935	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_21_D]
GSM6034936	Feces of a patient affected by limited (ACA) sclerodermia [F_22_L]
GSM6034937	Feces of a patient affected by limited (ACA) sclerodermia [F_23_L]
GSM6034938	Feces of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [F_24_D]
GSM6034939	Feces of a patient affected by limited (ACA) sclerodermia [F_25_L]
GSM6034940	Feces of a patient affected by limited (ACA) sclerodermia [F_26_L]
GSM6034941	Skin of a patient affected by limited (ACA) sclerodermia [C_01_L]
GSM6034942	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_02_D]
GSM6034943	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_03_D]
GSM6034944	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_04_D]
GSM6034945	Skin of a patient affected by limited (ACA) sclerodermia [C_05_L]
GSM6034946	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_06_D]
GSM6034947	Skin of a patient affected by limited (ACA) sclerodermia [C_07_L]
GSM6034948	Skin of a patient affected by limited (ACA) sclerodermia [C_08_L]
GSM6034949	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_09_D]
GSM6034950	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_10_D]
GSM6034951	Skin of a patient affected by limited (ACA) sclerodermia [C_11_L]
GSM6034952	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_12_D]
GSM6034953	Skin of a patient affected by limited (ACA) sclerodermia [C_13_L]
GSM6034954	Skin of a patient affected by limited (ACA) sclerodermia [C_14_L]
GSM6034955	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_15_D]
GSM6034956	Skin of a patient affected by limited (ACA) sclerodermia [C_16_L]
GSM6034957	Skin of a patient affected by limited (ACA) sclerodermia [C_17_L]
GSM6034958	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_18_D]
GSM6034959	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_19_D]
GSM6034960	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_20_D]
GSM6034961	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_21_D]
GSM6034962	Skin of a patient affected by limited (ACA) sclerodermia [C_22_L]
GSM6034963	Skin of a patient affected by limited (ACA) sclerodermia [C_23_L]
GSM6034964	Skin of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [C_24_D]
GSM6034965	Skin of a patient affected by limited (ACA) sclerodermia [C_25_L]
GSM6034966	Skin of a patient affected by limited (ACA) sclerodermia [C_26_L]
GSM6034967	Saliva of a patient affected by limited (ACA) sclerodermia [S_01_L]
GSM6034968	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_02_D]
GSM6034969	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_03_D]
GSM6034970	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_04_D]
GSM6034971	Saliva of a patient affected by limited (ACA) sclerodermia [S_05_L]
GSM6034972	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_06_D]
GSM6034973	Saliva of a patient affected by limited (ACA) sclerodermia [S_07_L]
GSM6034974	Saliva of a patient affected by limited (ACA) sclerodermia [S_08_L]
GSM6034975	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_09_D]
GSM6034976	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_10_D]
GSM6034977	Saliva of a patient affected by limited (ACA) sclerodermia [S_11_L]
GSM6034978	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_12_D]
GSM6034979	Saliva of a patient affected by limited (ACA) sclerodermia [S_13_L]
GSM6034980	Saliva of a patient affected by limited (ACA) sclerodermia [S_14_L]
GSM6034981	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_15_D]
GSM6034982	Saliva of a patient affected by limited (ACA) sclerodermia [S_16_L]
GSM6034983	Saliva of a patient affected by limited (ACA) sclerodermia [S_17_L]
GSM6034984	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_18_D]
GSM6034985	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_19_D]
GSM6034986	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_20_D]
GSM6034987	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_21_D]
GSM6034988	Saliva of a patient affected by limited (ACA) sclerodermia [S_22_L]
GSM6034989	Saliva of a patient affected by limited (ACA) sclerodermia [S_23_L]
GSM6034990	Saliva of a patient affected by diffuse (anti Scl70/RNA Pol III) sclerodermia [S_24_D]
GSM6034991	Saliva of a patient affected by limited (ACA) sclerodermia [S_25_L]
GSM6034992	Saliva of a patient affected by limited (ACA) sclerodermia [S_26_L]